New hope for sickle cell patients suffering from debilitating erections
NCT ID NCT03938454
Summary
This study tested whether a drug called crizanlizumab could reduce the frequency of painful, prolonged erections (priapism) in men with sickle cell disease. 36 male participants aged 12 and older, who experienced frequent priapism episodes, received the drug by IV infusion for one year. Researchers measured how much the drug reduced these events and monitored for side effects.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PRIAPISM are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Brody School of Medicine
Greenville, North Carolina, 27834, United States
-
Childrens Hosp Boston Dept of Hematology
Boston, Massachusetts, 02115, United States
-
Childrens National Hospital
Washington D.C., District of Columbia, 20010, United States
-
Duke University Medical Center
Durham, North Carolina, 27710, United States
-
Emory University School of Medicine
Atlanta, Georgia, 30303, United States
-
Foundation for Sickle Cell Disease Research
Hollywood, Florida, 33021, United States
-
LSU Medical Center
Shreveport, Louisiana, 71130, United States
-
Montefiore Medical Center
The Bronx, New York, 10461, United States
-
Prisma Health Upstate
Greenville, South Carolina, 29615, United States
-
University Of Alabama
Birmingham, Alabama, 35294, United States
-
University of Connecticut Health Center
Farmington, Connecticut, 06030, United States
-
University of Pittsburgh
Pittsburgh, Pennsylvania, 15213-2548, United States
-
University of Texas Medical School
Houston, Texas, 77030, United States
Conditions
Explore the condition pages connected to this study.